Background: Although so many experimental trials have been done to improve the redifferentiation and responsiveness of radioiodide therapy, they have not yet yielded any satisfactory results. As statins inhibit both farnesylation and geranylgeranylation, they have been reported to have an antineoplastic and redifferentiation effect in experimental and clinical studies. In this study, we investigated the relationship between statins and the alteration of the NIS expression and, TPC-1 cell apotosis to evaluate the possibility of using statins as adjuvant therapeutic agents for papillary thyroid cancer. Methods: We used the TPC-1 cell lines for our experiments. Cell viabilities were measured by CCK-8. The degrees of apoptosis and, the expressions of NIS mRNA and NIS protein were measured by flow cytometry, semi quantitative RT-PCR and Western blot assay. Results: Increased levels of NIS mRNA and NIS protein were observed under therapeutic blood concentrations (concentrations of simvastatin: 20, 50, 80 nM, concentrations of atorvastatin: 50, 80,110 nM), but the dose-response relationship was only manifested within simvastatin. The TPC-1 cells showed a concentration dependent decrease of viability and an increase of apoptosis not under therapeutic blood concentrations, but under excessively high concentrations (after treatment with 10-50 μM of atorvastatin and with 1-10 μM of simvastatin).
NIS mRNA 발현이 관찰되었으나, 농도 의존적이진 않았다 (Fig. 1) .
웨스턴 블롯(Western blot)
10 cm petri dish에 배양된 TPC-1 세포에 반정량적 semiquantita- (Fig. 3) .
스타틴 처리 후 각 세포의 농도에 따른 유세포 분석

TPC-1 세포를 대조군과 각각 일정한 고농도의 스타틴을 투여한 군으로 나누어 살아있는 세포, 고사된 세포 및 죽은 세포로 나누어 농도에 따른 세포분획의 변화를 관찰하였다. 대조군에 비해 스타틴 투여 군에서 농도에 따라 살아있는 세포의 비율이 감소되면서 고사 된 세포의 비율이 점차로 증가되어 농도에 따른 세포자멸사의 진행
을 관찰할 수 있었다 (Fig. 4) . 
